在NICU中使用粘结剂和吸入抗生素
Alexander I Gipsman1, Anita Bhandari1,2, Vineet Bhandari3,4
1Division of Pulmonary and Sleep Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
概括
在NICU治疗呼吸道感染和清除气道粘液是一项挑战. 吸入性粘菌剂和抗生素可能为婴儿提供更安全,更有效的选择,但需要更多的研究.
科学领域:
- 新生儿重症监护室新生儿重症监护室
- 呼吸系统药物 呼吸系统药物
- 药理学 药理学是指药理学的学科.
背景情况:
- 呼吸道分泌物清除和呼吸道感染 (RTI) 治疗在新生儿重症监护室 (NICU) 中至关重要.
- 目前的治疗方法,如对RTIs的全身抗生素,具有不良影响,而粘菌剂对新生儿的研究较少.
- 婴儿的生理差异需要特殊的研究,与成人和较老的儿科数据不同.
研究的目的:
- 解决在NICU中基于证据的吸入性粘菌剂和抗生素使用的需要.
- 评估这些吸入疗法在新生儿中的安全性,疗效和最佳剂量.
- 弥合有关早产和满期婴儿呼吸系统护理的知识差距.
主要方法:
- 对新生儿群体吸入性粘结剂和抗生素现有文献的综述.
- 对病例系列和小型研究进行分析,描述它们在NICU中的使用.
- 识别知识缺口和未来临床试验的领域.
主要成果:
- 关于新生儿重症监护室内吸入的粘菌剂和抗生素的数据有限,小型病例系列提供了初步见解.
- 系统性抗生素用于RTIs是常见的,但与不良影响有关.
- 吸入性抗生素显示出有潜力的向输送和降低全身毒性.
结论:
- 迫切需要确定吸入性粘菌剂和新生儿抗生素的安全性和有效性.
- 需要进一步的研究来确定不同妊娠和产后年龄的最佳剂量策略.
- 制定基于证据的指导方针,用于NICU的吸入呼吸道治疗,对于改善婴儿结果至关重要.
相关概念视频
01:16Drugs Used in Upper Respiratory Disorders: Overview
177
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
177
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
232
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
232
01:23Inhaled Medications
237
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237
01:17Drugs Used in Lower Respiratory Disorders: Overview
352
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
352
01:29Acute Respiratory Failure-V
123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123
01:24Cystic Fibrosis: Management
142
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
142